Domů › Rakovina prostaty › Kalifornie › San Francisco
Klinické studie Rakovina prostaty v San Francisco, CA
45 studií pro Rakovina prostaty hledá účastníky v lokalitách v San Francisco a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Probíhá náborFáze 3
- Kaiser Permanente-San Francisco, San Francisco
Distance-Based Exercise to Preserve Function and Prevent Disability
Probíhá nábor
- Kaiser Permanente-San Francisco, San Francisco
Precision-Based Genomics in Prostate Cancer
Probíhá náborObservační studie
- University of California San Francisco, San Francisco
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Probíhá náborFáze 3
- San Francisco VA Health Care System ( Site 0093), San Francisco
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Probíhá náborFáze 3
- University of California San Francisco, San Francisco
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Probíhá nábor
- University of California San Francisco, San Francisco
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Probíhá náborFáze 3
- Kaiser Permanente-San Francisco, San Francisco
Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer
Probíhá náborFáze 2
- University of California, San Francisco, San Francisco
Prostate Active Surveillance Study
Probíhá náborObservační studie
- Veterans Affairs San Francisco Health Care System, San Francisco
- University of California, San Francisco, San Francisco
A Study of Tarlatamab for People With Prostate Cancer
Probíhá náborFáze 2
- University of California San Francisco, San Francisco
Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617
Probíhá náborFáze 1
- University of California, San Francisco, San Francisco
COMPASS Study for Metastatic Castration-resistant Prostate Cancer
Probíhá náborObservační studie
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
Probíhá náborFáze 3
- Research Site, San Francisco
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Probíhá náborFáze 1
- University of California San Francisco, San Francisco
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Probíhá náborFáze 2
- University of California San Francisco, San Francisco
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Probíhá náborFáze 1/2
- University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Probíhá náborFáze 1
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Probíhá náborFáze 1/2
- Research Site, San Francisco
A Study of DM002 in Patients With Advanced Solid Tumors
Probíhá náborFáze 1/2
- University of California San Francisco Cancer Center, San Francisco
Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
Probíhá náborFáze 1
- University of California San Francisco, San Francisco
Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer
Probíhá náborFáze 1/2
- University of California, San Francisco, San Francisco
PSMA PET Combined With MRI for the Detection of PCa
Probíhá náborFáze 3Vítáni zdraví dobrovolníci
- University of California San Francisco, San Francisco
Imaging of Solid Tumors Using 18F-TRX
Probíhá náborFáze 1
- University of California, San Francisco, San Francisco
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Probíhá náborFáze 1
- University of California San Francisco, San Francisco
Social, Structural, and Lifestyle Drivers of Prostate Cancer Disparities
Probíhá náborObservační studie
- University of California, San Francisco, San Francisco
Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease
Probíhá náborFáze 2
- University of California San Francisco, San Francisco
Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
Probíhá náborFáze 1
- University of California San Francisco, San Francisco
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
Probíhá náborFáze 2
- University of California, San Francisco, San Francisco
177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer
Probíhá náborFáze 1
- University of California, San Francisco, San Francisco
Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active Surveillance
Probíhá náborFáze 2
- University of California, San Francisco, San Francisco
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- University of California, San Francisco, San Francisco
Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr
Probíhá nábor
- UCSF, San Francisco
Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate Cancer
Probíhá náborRaná fáze 1
- University of California, San Francisco, San Francisco
Tumor Genomic Pre-test Counseling Tool for Black or African-American Men With Prostate Cancer
Probíhá nábor
- University of California, San Francisco
Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
Probíhá náborFáze 3
- Kaiser Permanente-San Francisco, San Francisco
Mechanisms of Resistance to PSMA Radioligand Therapy
Probíhá náborObservační studie
- University of California, San Francisco, San Francisco
64Cu-GRIP B in Patients With Advanced Malignancies
Probíhá náborFáze 1/2
- University of California, San Francisco, San Francisco
Patient Decision-making About Precision Oncology in Veterans With Advanced Prostate Cancer
Probíhá nábor
- San Francisco Veterans Affairs Medical Center, San Francisco
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Probíhá náborFáze 1/2
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Probíhá náborFáze 1
- University of California San Francisco, San Francisco
Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer
Probíhá náborFáze 2
- University of California, San Francisco, San Francisco
Community-Based Health Coach for Access to Germline Genetic Testing Among African American Men With Prostate Cancer
Probíhá nábor
- Zuckerberg San Francisco General Hospital, San Francisco
- San Francisco Veterans Administration Medical Center, San Francisco
- University of California San Francisco, San Francisco
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Probíhá náborObservační studie
- Massive Bio SYNERGY-AI site, San Francisco
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Probíhá náborFáze 3
- Kaiser Permanente-San Francisco, San Francisco
ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate Cancer
Probíhá náborObservační studie
- University of California, San Francisco, San Francisco
Studie Rakovina prostaty v jiných městech
- New York City, NY103 studií
- Houston, TX76 studií
- Los Angeles, CA61 studií
- Boston, MA59 studií
- St. Louis, MO46 studií
- Chicago, IL45 studií
- Philadelphia, PA44 studií
- Baltimore, MD43 studií
- Nashville, TN42 studií
- Seattle, WA42 studií
- Washington, DC38 studií
- Dallas, TX36 studií
Další studie v San Francisco
- Rakovina prsu43 studií
- Nemalobuněčný plicní karcinom36 studií
- Rakovina (všechny typy)35 studií
- Srdeční selhání29 studií
- Metastatický karcinom28 studií
- Rakovina plic23 studií
- Melanom22 studií
- Rakovina slinivky břišní20 studií
- Rakovina vaječníků19 studií
- Kolorektální karcinom18 studií
- Kardiovaskulární onemocnění18 studií
- Glioblastom17 studií
Zdroj: ClinicalTrials.gov, data načtena 5. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.